Evidence map›Paper›PMID 28205584›Full record

ArticleScientific reports2017

A postnatal role for embryonic myosin revealed by MYH3 mutations that alter TGFβ signaling and cause autosomal dominant spondylocarpotarsal synostosis.

Jennifer Zieba, Wenjuan Zhang, Jessica X Chong, Kimberly N Forlenza, Jorge H Martin, Kelly Heard, Dorothy K Grange, Merlin G Butler, Tjitske Kleefstra, Ralph S Lachman and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Preoperative halo traction for rigid spinal deformity in contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B: a case report and literature review.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Review
  3. Article
  4. Article
  5. NovelJournal of pediatric genetics · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jennifer ZiebaDepartment of Human Genetics, David Geffen School of Medicine at UCLA, California, 90095, USA.
Wenjuan ZhangDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California, 90095, USA.
Jessica X ChongDepartment of Genome Sciences, University of Washington, Seattle, Washington 98195, USA.
Kimberly N ForlenzaDepartment of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, 90095, USA.
Jorge H MartinDepartment of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, 90095, USA.
Kelly HeardDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California, 90095, USA.
Dorothy K GrangeDivision of Genetics and Genomic Medicine, Department of Pediatrics, Washington University School of Medicine, Saint Louis, Missouri, USA.
Merlin G ButlerDepartments of Psychiatry &Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, KS, USA.
Tjitske KleefstraDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Ralph S LachmanInternational Skeletal Dysplasia Registry, University of California Los Angeles, Los Angeles, California, 90095, USA.
Deborah NickersonDepartment of Genome Sciences, University of Washington, Seattle, Washington 98195, USA.
Michael RegnierDepartment of Bioengineering, University of Washington, Seattle, WA, USA.
Daniel H CohnDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California, 90095, USA.
Michael BamshadDepartment of Genome Sciences, University of Washington, Seattle, Washington 98195, USA.
Deborah KrakowDepartment of Human Genetics, David Geffen School of Medicine at UCLA, California, 90095, USA.

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
UW Center for Mendelian GenomicsU54HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, NICKERSON, DEBORAH A · 2012 to 2015
$20.0M
UW Center for Mendelian GenomicsUM1HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, LEAL, SUZANNE M · 2016 to 2020
$15.3M
Exome sequencing in the skeletal dysplasiasR01AR062651 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI COHN, DANIEL H · 2013 to 2017
$1.7M
Unraveling the mechanisms of prenatal-onset disorders affecting the skeletonR01AR066124 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KRAKOW, DEBORAH · 2014 to 2018
$1.7M
FLMNB causes progressive skeletal fusions via TGF-Beta/BMP signaling modulationF31AR066487 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZIEBA, JENNIFER · 2015 to 2016
$60k
NCATS NIH HHS UL1 TR000124NHGRI NIH HHS U54 HG006493NHGRI NIH HHS UM1 HG006493NIAMS NIH HHS F31 AR066487NIAMS NIH HHS R01 AR062651NIAMS NIH HHS R01 AR066124
6 · The paper itself

Abstract

Spondylocarpotarsal synostosis (SCT) is a skeletal disorder characterized by progressive vertebral, carpal and tarsal fusions, and mild short stature. The majority of affected individuals have an autosomal recessive form of SCT and are homozygous or compound heterozygous for nonsense mutations in the gene that encodes the cytoskeletal protein filamin B (FLNB), but a subset do not have FLNB mutations. Exome sequence analysis of three SCT patients negative for FLNB mutations identified an autosomal dominant form of the disease due to heterozygosity for missense or nonsense mutations in MYH3, which encodes embryonic myosin. Cells transfected with the MYH3 missense mutations had reduced TGFβ signaling, revealing a regulatory role for embryonic myosin in the TGFβ signaling pathway. In wild-type mice, there was persistent postnatal expression of embryonic myosin in the small muscles joining the neural arches of the spine suggesting that loss of myosin function in these muscles contribute to the disease. Our findings demonstrate that dominant mutations in MYH3 underlie autosomal dominant SCT, identify a postnatal role for embryonic myosin and suggest that altered regulation of signal transduction in the muscles within the spine may lead to the development of vertebral fusions.

Indexed as

Genes, DominantMutationSignal TransductionAbnormalities, MultipleAllelesBone Morphogenetic ProteinsCytoskeletal ProteinsExome SequencingFemaleGenotypeHumansLumbar VertebraeMaleMusculoskeletal DiseasesMyosinsPhenotypeBone Morphogenetic ProteinsCytoskeletal ProteinsMYH3 polypeptide, humanMyosinsTransforming Growth Factor beta

Identifiers

PMID28205584
PMCPMC5311977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.